These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35152039)

  • 21. COVID-19 Recovery Patterns Across Alpha (B.1.1.7) and Delta (B.1.617.2) Variants of SARS-CoV-2.
    Kumar N; Quadri S; AlAwadhi AI; AlQahtani M
    Front Immunol; 2022; 13():812606. PubMed ID: 35237265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 Infection and Hospitalization Among Adults Aged ≥18 Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variant Predominance - Los Angeles County, California, November 7, 2021-January 8, 2022.
    Danza P; Koo TH; Haddix M; Fisher R; Traub E; OYong K; Balter S
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(5):177-181. PubMed ID: 35113851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
    Babouee Flury B; Güsewell S; Egger T; Leal O; Brucher A; Lemmenmeier E; Meier Kleeb D; Möller JC; Rieder P; Rütti M; Schmid HR; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Kuster SP; Kahlert CR; Kohler P;
    PLoS Med; 2022 Nov; 19(11):e1004125. PubMed ID: 36342956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BNT162b2 and ChAdOx1 nCoV-19 vaccinations, incidence of SARS-CoV-2 infections and COVID-19 hospitalisations in Scotland in the Delta era.
    Shah SA; Robertson C; Rudan I; Murray JL; McCowan C; Grange Z; Buelo A; Sullivan C; Simpson CR; Ritchie LD; Sheikh A
    J Glob Health; 2022; 12():05008. PubMed ID: 35356660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transmission of and Infection With COVID-19 Among Vaccinated and Unvaccinated Attendees of an Indoor Wedding Reception in Minnesota.
    Wienkes H; Vilen K; Lorentz A; Gerlach D; Wang X; Saupe A; Danila R; Lynfield R; Smith K; Medus C
    JAMA Netw Open; 2022 Feb; 5(2):e220536. PubMed ID: 35212747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shift in SARS-CoV-2 variants of concern from Delta to Omicron was associated with reduced hospitalizations, increased risk of breakthrough infections but lesser disease severity.
    Mwendwa F; Kanji A; Bukhari AR; Khan U; Sadiqa A; Mushtaq Z; Nasir N; Mahmood SF; Aamir UB; Hasan Z
    J Infect Public Health; 2024 Jun; 17(6):1100-1107. PubMed ID: 38714122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study.
    Md Yusof MY; Arnold J; Saleem B; Vandevelde C; Dass S; Savic S; Vital EM; Emery P
    Lancet Rheumatol; 2023 Feb; 5(2):e88-e98. PubMed ID: 36712951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transmission potential of vaccinated and unvaccinated persons infected with the SARS-CoV-2 Delta variant in a federal prison, July-August 2021.
    Salvatore PP; Lee CC; Sleweon S; McCormick DW; Nicolae L; Knipe K; Dixon T; Banta R; Ogle I; Young C; Dusseau C; Salmonson S; Ogden C; Godwin E; Ballom T; Rhodes T; Wynn NT; David E; Bessey TK; Kim G; Suppiah S; Tamin A; Harcourt JL; Sheth M; Lowe L; Browne H; Tate JE; Kirking HL; Hagan LM
    Vaccine; 2023 Mar; 41(11):1808-1818. PubMed ID: 36572604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of vaccination on the symptoms of hospitalised patients with SARS-CoV-2 Delta variant (B.1.617.1) infection.
    Epaulard O; Abgrall S; Lefebvre M; Faucher JF; Michon J; Frentiu E; Blanchi S; Janssen C; Charbonnier G; Fresse A; Laurent S; Sandjakian L; Casez P; Mahamat A; Beraud G
    Clin Microbiol Infect; 2022 Dec; 28(12):1629-1635. PubMed ID: 35779764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breakthrough SARS-CoV-2 infection outcomes in vaccinated patients with chronic liver disease and cirrhosis: A National COVID Cohort Collaborative study.
    Ge J; Digitale JC; Pletcher MJ; Lai JC;
    Hepatology; 2023 Mar; 77(3):834-850. PubMed ID: 36799617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 Breakthrough Infections and Transmission Risk: Real-World Data Analyses from Germany's Largest Public Health Department (Cologne).
    Hsu L; Grüne B; Buess M; Joisten C; Klobucnik J; Nießen J; Patten D; Wolff A; Wiesmüller GA; Kossow A; Hurraß J
    Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination Decreases the Infectious Viral Load of Delta Variant SARS-CoV-2 in Asymptomatic Patients.
    Plante JA; Machado RRG; Mitchell BM; Shinde DP; Walker J; Scharton D; McConnell A; Saada N; Liu J; Khan B; Campos RK; Johnson BA; Menachery VD; Levine CB; Ren P; McLellan SLF; Plante KS; Weaver SC
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical features of children with coronavirus disease 2019 Delta variant infection after vaccination with inactivated SARS-CoV-2 vaccine].
    Su H; Zhang X; Duan FY; Ren XQ; Yan YB; Ding Y
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jul; 24(7):742-747. PubMed ID: 35894187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies.
    Boekel L; Stalman EW; Wieske L; Hooijberg F; van Dam KPJ; Besten YR; Kummer LYL; Steenhuis M; van Kempen ZLE; Killestein J; Volkers AG; Tas SW; van der Kooi AJ; Raaphorst J; Löwenberg M; Takkenberg RB; D'Haens GRAM; Spuls PI; Bekkenk MW; Musters AH; Post NF; Bosma AL; Hilhorst ML; Vegting Y; Bemelman FJ; Voskuyl AE; Broens B; Parra Sanchez A; van Els CACM; de Wit J; Rutgers A; de Leeuw K; Horváth B; Verschuuren JJGM; Ruiter AM; van Ouwerkerk L; van der Woude D; Allaart CF; Teng YKO; van Paassen P; Busch MH; Jallah PBP; Brusse E; van Doorn PA; Baars AE; Hijnen DJ; Schreurs CRG; van der Pol WL; Goedee HS; Vogelzang EH; Leeuw M; Atiqi S; van Vollenhoven R; Gerritsen M; van der Horst-Bruinsma IE; Lems WF; Nurmohamed MT; Boers M; Keijzer S; Keijser J; van de Sandt C; Boogaard A; Cristianawati O; Ten Brinke A; Verstegen NJM; Zwinderman KAH; van Ham SM; Rispens T; Kuijpers TW; Wolbink G; Eftimov F;
    Lancet Rheumatol; 2022 Jun; 4(6):e417-e429. PubMed ID: 35527808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave.
    Tan ST; Kwan AT; Rodríguez-Barraquer I; Singer BJ; Park HJ; Lewnard JA; Sears D; Lo NC
    Nat Med; 2023 Feb; 29(2):358-365. PubMed ID: 36593393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunologic features of asymptomatic postvaccination infections with the Delta variant of SARS-CoV-2 in adults.
    Duan R; Mao Q; Ding X; Qiu Q; Wang P
    Immun Inflamm Dis; 2022 Jul; 10(7):e670. PubMed ID: 35759224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US.
    Sun J; Zheng Q; Madhira V; Olex AL; Anzalone AJ; Vinson A; Singh JA; French E; Abraham AG; Mathew J; Safdar N; Agarwal G; Fitzgerald KC; Singh N; Topaloglu U; Chute CG; Mannon RB; Kirk GD; Patel RC;
    JAMA Intern Med; 2022 Feb; 182(2):153-162. PubMed ID: 34962505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar.
    Butt AA; Dargham SR; Chemaitelly H; Al Khal A; Tang P; Hasan MR; Coyle PV; Thomas AG; Borham AM; Concepcion EG; Kaleeckal AH; Latif AN; Bertollini R; Abou-Samra AB; Abu-Raddad LJ
    JAMA Intern Med; 2022 Feb; 182(2):197-205. PubMed ID: 34935861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case report of breakthrough infection with the SARS-CoV-2 delta variant and household transmission: Role of vaccination, anti-spike IgG and neutralizing activity.
    Moriyama Y; Ishikane M; Ueno M; Matsunaga A; Ishizaka Y; Arashiro T; Kanno T; Suzuki T; Kimura K
    J Infect Chemother; 2022 Jul; 28(7):962-964. PubMed ID: 35461768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigating SARS-CoV-2 breakthrough infections per variant and vaccine type.
    Dingemans J; van der Veer BMJW; Gorgels KMF; Hackert V; den Heijer CDJ; Hoebe CJPA; Savelkoul PHM; van Alphen LB
    Front Microbiol; 2022; 13():1027271. PubMed ID: 36504818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.